The trading price of Verrica Pharmaceuticals Inc (NASDAQ:VRCA) floating lower at last check on current market day and closing at $0.84, -2.92% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $0.7938 and $0.95. In examining the 52-week price action we see that the stock hit a 52-week high of $8.98 and a 52-week low of $0.38. Over the past month, the stock has gained 36.81% in value.
Verrica Pharmaceuticals Inc, whose market valuation is $77.39 million at the time of this writing, is expected to release its quarterly earnings report on 2025-May-13. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.08 per share this quarter, however they have predicted annual earnings per share of -0.33 for current year and -0.24 for next year.
Analysts have forecast the company to bring in revenue of 4.37M for the current quarter, with the likely lows of 3M and highs of 5.1M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 19.62M.
On the technical side, indicators suggest VRCA has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a Hold, while an average of long term indicators suggests that the stock is currently 50% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned VRCA a recommendation rating is 4. Out of them, 0 rate it a Hold, while 4 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Verrica Pharmaceuticals Inc (VRCA) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that VRCA’s price is currently 29.82% off the SMA20 and 43.99% off the SMA50. The RSI metric on the 14-day chart is currently showing 70.16, and weekly volatility stands at 16.48%. When measured over the past 30 days, the indicator reaches 11.47%. Verrica Pharmaceuticals Inc (NASDAQ:VRCA)’s beta value is currently sitting at 1.88. With analysts defining $10-$14 as the low and high price targets, we arrive at a consensus price target of $12 for the trailing 12-month period. The current price is about -1090.48% off the estimated low and -1566.67% off the forecast high, based on this estimate. Investors will be thrilled if VRCA’s share price rises to $12, which is the median consensus price. At that level, VRCA’s share price would be -1328.57% below current price.
To see how Verrica Pharmaceuticals Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: VRCA stock’s performance was -2.92% at last check in today’s session, and 19.53% in the past year.
An evaluation of the daily trading volume of Verrica Pharmaceuticals Inc (NASDAQ:VRCA) indicates that the 3-month average is 406.52K. However, this figure has increased over the past 10 days to an average of 1.11.
Currently, records show that 91.79 million of the company’s shares remain outstanding. The insiders hold 45.85% of outstanding shares, whereas institutions hold 31.86%. The stats also highlight that short interest as of 2025-06-13, stood at 2.97 million shares, resulting in a short ratio of 10.78 at that time. From this, we can conclude that short interest is 578.00 of the company’s total outstanding shares. It is noteworthy that short shares in June were down slightly from the previous month’s figure, which was 3.15 million. However, since the stock’s price has seen -89.03% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
